NCT07876830Not yet recruiting
Effect of Artificial Intelligent-based Training and Benson Relaxation Exercises on Caregiver Burden and Stress Levels in Caregivers of Patients With Parkinson's Disease
Artificial Intelligent-based Training and Benson Relaxation Exercises on Caregiver Burden and Stress Levels in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The aim of this study is to evaluate the effect of artificial intelligence-supported training and the Benson relaxation exercise on the care burden and stress levels of caregivers of people with Parkinson's disease. In the study, caregivers of people with Parkinson's disease will receive training on caring for people with Parkinson's disease and on the Benson relaxation exercise. The training sessions will be conducted using an artificial intelligence-based module. Participants will be randomly assigned to three groups: a training group, an exercise group, and a control group. A caregiver information form, the Modified Hoehn and Yahr Scale, the Zarit Caregiver Burden Scale, and the Caregiver Stress Scale will be used to collect pretest data from all participants during the initial interview. The training sessions for the experimental group will last 4 weeks. No training will be provided to the control group. Four weeks later, the Zarit Caregiver Burden Scale and the Caregiver Stress Scale will be used to collect final test data from the experimental and control groups. The hypotheses related to this study are as follows: * Artificial intelligence-supported training provided to caregivers of people with Parkinson's disease affects the burden of care. * The Benson relaxation exercise provided to caregivers of people with Parkinson's disease affects the burden of care. * Artificial intelligence-supported training provided to caregivers of people with Parkinson's disease affects stress levels. * The Benson relaxation exercise administered to caregivers of people with Parkinson's disease affects stress levels.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- First submitted
- 9 Oct 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 30 May 2027
- Lead sponsor
- Ataturk University
- Diseases
- Parkinson disease
- NCT number
- NCT07876830
What you commit to
- Study type: Interventional
- Planned participants: 102
- From 1 Nov 2026 to the primary completion date, 30 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Having visual, auditory, or cognitive communication barriers
Who the study is looking for
- Be 18 years of age or older
- Be a family member of the patient (spouse, daughter, son, etc.)
- Living in the same household as the patient
- Having cared for the patient for at least 6 months
- Being the primary caregiver responsible for the patient's care
- There being no paid staff member in the home to assist the caregiver
- Having no health issues that prevent communication
- Being able to read and write
- Having access to a phone for communication
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.